![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Lipomed Ag Arlesheim Ch, based in Switzerland, is a pharmaceutical company.
One of their significant offerings is Cladribine, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-076 - Rev 00
This Chemical Type CEP, issued on April 05, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2174 associated with this CEP further emphasizes